Crossmark

CB13, a novel PPARγ ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancer

Published Online: 2020-10-13

Authors

Kim, Tae Woo

Hong, Da-Won

Hong, Sung Hee
License Information

Text and Data Mining valid from 2020-10-13

Version of Record valid from 2020-10-13
More Information

Article History

Received: 20 December 2019

Revised: 20 August 2020

Accepted: 24 August 2020

First Online: 13 October 2020

Conflict of interest

: The authors declare that they have no conflict of interest.

Document is current